123941-49-1

Basic information

• Product Name: xylazole
• Synonyms: xylazole;N-(2,6-Dimethylphenyl)-2-thiazolamine hydrochloride
• CAS NO: 123941-49-1
• Molecular Formula: C11H12N2S.ClH
• Molecular Weight: 240.757
• Mol File: 123941-49-1.mol
• Article Data: 0

Chemical Properties

• Boiling Point: 313.7 °C at 760 mmHg
• Flash Point: 143.5 °C
• Appearance: /
• Vapor Pressure: 0.000487mmHg at 25°C
• Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
• CAS DataBase Reference: xylazole(CAS DataBase Reference)
• NIST Chemistry Reference: xylazole(123941-49-1)
• EPA Substance Registry System: xylazole(123941-49-1)

Safety Data

• Hazardous Substances Data: 123941-49-1(Hazardous Substances Data)

Usage

Description

Xylazine is a veterinary medication characterized by its sedative, analgesic, and muscle relaxant properties. It is specifically designed for use in animals, where it operates by stimulating receptors within the central nervous system to induce sedation and muscle relaxation. While considered safe for animals when used correctly, it requires careful administration due to potential adverse effects such as bradycardia, hypotension, and respiratory depression. It is not intended for human use and should be administered under the supervision of a veterinarian.

Uses

Used in Veterinary Medicine:
Xylazine is used as a sedative to calm animals and facilitate veterinary procedures, allowing for easier handling and examination.
Xylazine is used as an analgesic to alleviate pain in animals, providing comfort during medical interventions.
Xylazine is used as a muscle relaxant to reduce muscle tension and facilitate certain medical or surgical procedures.
Used in Combination Therapy:
Xylazine is used in combination with other drugs for enhanced sedation and anesthesia during veterinary procedures, providing a more controlled and effective state of relaxation for the animal.
Used under Veterinary Supervision:
Xylazine is used under the direct supervision of a veterinarian to ensure safe and appropriate administration, monitoring for any adverse effects, and adjusting the treatment as necessary to maintain the animal's health and well-being.

InChI:InChI=1/C11H12N2S.ClH/c1-8-4-3-5-9(2)10(8)13-11-12-6-7-14-11;/h3-7H,1-2H3,(H,12,13);1H